Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02535338. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progr
ClinicalTrials.gov study NCT04042558. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor
ClinicalTrials.gov study NCT00314262. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy
ClinicalTrials.gov study NCT01417936. IPD Sharing: UNDECIDED. Countries: 3. Publications: 1.
A Study of Atezolizumab in Combination With Bevacizumab in Patients With EGFR Mutation Positive Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04426825. IPD Sharing: YES. Countries: 1. Publications: 1.
Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)
ClinicalTrials.gov study NCT04248829. IPD Sharing: YES. Countries: 13. Publications: 2.
Efficacy, Safety, Tolerability of Gefitinib as 1st Line in Caucasian Patients With EGFR Mutation Positive Advanced NSCLC
ClinicalTrials.gov study NCT01203917. IPD Sharing: Not stated. Countries: 13. Publications: 1.
GIOTRIF in First Line Therapy of Advanced NSCLC With EGFR-mutations
ClinicalTrials.gov study NCT02047903. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption
ClinicalTrials.gov study NCT03115567. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations
ClinicalTrials.gov study NCT01310036. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
ClinicalTrials.gov study NCT01187901. IPD Sharing: NO. Countries: 1. Publications: 3.
Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib
ClinicalTrials.gov study NCT02759835. IPD Sharing: YES. Countries: 1. Publications: 2.
Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers
ClinicalTrials.gov study NCT02803203. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients
ClinicalTrials.gov study NCT01526928. IPD Sharing: Not stated. Countries: 4. Publications: 2.
The BASE Study: Bicarbonate Administration to Stabilize Estimated Glomerular Filtration Rate (eGFR)
ClinicalTrials.gov study NCT02521181. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.
ClinicalTrials.gov study NCT00503971. IPD Sharing: NO. Countries: 1. Publications: 1.
Hypertrophic cardiomyopathy-associated mutations drive stromal activation via EGFR-mediated paracrine signaling
Open the record for dataset details and reuse information.
Data from: Oncogenic transformation by inhibitor-sensitive and resistant EGFR mutants
Open the record for dataset details and reuse information.
Data from: Allospecific splenic Tr1 cells drive effector T cell exhaustion through upregulated Areg-EGFR signaling to promote transplant tolerance
Open the record for dataset details and reuse information.
Millions of lung tumors harboring KRAS, BRAF, EGFR, and tumor suppressor alterations from genetically engineered mouse models
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.